Enzychem Lifesciences Corp (XKRX:183490) Share Price

Company Profile

Business description
Enzychem Lifesciences Corp develops and produces APIs and functional health foods. The company's business divisions are divided into the Global New Drug Development, Pharmaceutical Active Ingredients, and Health Functional Foods divisions, as well as the Bio-oil (HVO raw materials, SAF raw materials) business division of its subsidiary. The products of the company include erdosteine (cough suppressant/expectorant), gadobutrol (contrast agent), D-cycloserine (anti-tuberculosis agent), sarpogrelate (anticoagulant), zinc carnosine (anti-ulcer agent), and zaltoprofen (anti-inflammatory analgesic), and others.
Contact
59, Biovalley-ro
Wangam-dong
Jecheon-siChungcheongbuk-do135-280
KOR
T: +82 436522845
https://www.enzychem.co.kr
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
130

Recommended

We now forecast mildly better revenue growth and EPS growth, alongside more intense near-term cash flow pressure.

Eric Compton, CFA | 29 October 2026

We believe that investors are underappreciating the breadth and depth of Alphabet’s AI monetization and the rapid upcoming growth in Google Cloud.

Malik Ahmed Khan, CFA | 29 October 2026

Solid results included strong full-self driving software uptake and positive free cash flow.

Seth Goldstein, CFA | 29 October 2026

Index	Last price	Change	% Change
All Ordinaries	9,012.60	41.20	0.46%
CAC 40	7,970.00	83.04	1.05%
DAX 40	26,039.68	335.66	1.31%
Dow JONES (US)	52,342.56	132.54	-0.25%
FTSE 100	10,722.07	27.57	0.26%
HKSE	22,958.65	136.18	-0.59%
NASDAQ	26,184.72	365.13	-1.38%
Nikkei 225	64,659.47	705.28	1.10%
NZX 50 Index	13,710.17	0.00	0.00%
S&P 500	7,720.39	23.59	-0.30%
S&P/ASX 200	8,891.80	44.50	0.50%
SSE Composite Index	3,651.43	30.04	-0.82%